These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 9108785

  • 1. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.
    Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN.
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):715-22. PubMed ID: 9108785
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH.
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
    Knowlton N, Wages JA, Centola MB, Giles J, Bathon J, Quiroga C, Alaupovic P.
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):993-1000. PubMed ID: 22337612
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 7. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
    Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, Krauss RM.
    Circulation; 1997 Apr 15; 95(8):2022-6. PubMed ID: 9133510
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E, Corder C, Mueller G, Centurion H, Hallum G, Fesmire J, McConathy WD, Alaupovic P.
    Atherosclerosis; 1996 Apr 26; 122(1):105-15. PubMed ID: 8724117
    [Abstract] [Full Text] [Related]

  • 9. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P, Heinonen T, Shurzinske L, Black DM.
    Atherosclerosis; 1997 Aug 26; 133(1):123-33. PubMed ID: 9258416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.
    Mack WJ, Krauss RM, Hodis HN.
    Arterioscler Thromb Vasc Biol; 1996 May 26; 16(5):697-704. PubMed ID: 8963728
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
    Alaupovic P, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Samuelsson O.
    Kidney Int; 2006 May 26; 69(10):1865-71. PubMed ID: 16572113
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ, Bard JM, Fruchart JC, Ordovas JM, Wilson PF, Schaefer EJ.
    Atherosclerosis; 1991 Oct 26; 90(2-3):149-57. PubMed ID: 1684707
    [Abstract] [Full Text] [Related]

  • 16. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H, Perlov D, Khoo C, Sacks FM.
    J Lipid Res; 2001 Aug 01; 42(8):1239-49. PubMed ID: 11483625
    [Abstract] [Full Text] [Related]

  • 19. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA, Stentz F, Gettys T, Smith SR.
    Metabolism; 2006 Jan 01; 55(1):26-34. PubMed ID: 16324916
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.